Active Ingredient(s):Indacaterol Maleate FDA Approved: * July 1, 2011 Pharm Company: *NOVARTIS PHARMS Category:Lungs (Pulmonary)
Indacaterol is an ultra-long-acting beta-adrenoceptor agonist developed by Novartis. It needs to be taken only once a day, unlike the related drugs formoterol and salmeterol. It is licensed only for the treatment of chronic obstructive pulmonary disease (COPD) (long-term data in patients with asthma are thus far lacking). It is delivered as an aerosol formulation through a dry powder inhaler.
A Cochrane review found benefit in lung functi...
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion